CONTRI, CHIARA

CONTRI, CHIARA  

Dipartimento di Medicina Traslazionale e per la Romagna  

Mostra records
Risultati 1 - 11 di 11 (tempo di esecuzione: 0.023 secondi).
Titolo Data di pubblicazione Autore(i) File
Adenosine and inflammation: Here, there and everywhere 2021 Pasquini, S.; Contri, C.; Borea, P. A.; Vincenzi, F.; Varani, K.
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets 2022 Pasquini, S.; Contri, C.; Merighi, S.; Gessi, S.; Borea, P. A.; Varani, K.; Vincenzi, F.
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence 2024 Bedini, Annalida; Elisi, Gian Marco; Fanini, Fabiola; Retini, Michele; Scalvini, Laura; Pasquini,... Silvia; Contri, Chiara; Varani, Katia; Spadoni, Gilberto; Mor, Marco; Vincenzi, Fabrizio; Rivara, Silvia file con accesso da definire
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? 2023 Merighi, Stefania; Travagli, Alessia; Nigro, Manuela; Pasquini, Silvia; Cappello, Martina; Contri..., Chiara; Varani, Katia; Vincenzi, Fabrizio; Borea, Pier Andrea; Gessi, Stefania
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 2023 Papa, Alessandro; Pasquini, Silvia; Galvani, Francesca; Cammarota, Mariarosaria; Contri, Chiara; ...Carullo, Gabriele; Gemma, Sandra; Ramunno, Anna; Lamponi, Stefania; Gorelli, Beatrice; Saponara, Simona; Varani, Katia; Mor, Marco; Campiani, Giuseppe; Boscia, Francesca; Vincenzi, Fabrizio; Lodola, Alessio; Butini, Stefania
PHARMACOLOGICAL CHARACTERIZATION OF NEW MODULATORS OF THE ENDOCANNABINOID SYSTEM: FROM SINGLE TARGET TO MULTI-TARGET COMPOUNDS 2024 Contri, Chiara
Pharmacology of Adenosine Receptors: Recent Advancements 2023 Vincenzi, Fabrizio; Pasquini, Silvia; Contri, Chiara; Cappello, Martina; Nigro, Manuela; Travagli..., Alessia; Merighi, Stefania; Gessi, Stefania; Borea, Pier Andrea; Varani, Katia file con accesso da definire
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents 2023 Papa, Alessandro; Cursaro, Ilaria; Pozzetti, Luca; Contri, Chiara; Cappello, Martina; Pasquini, S...ilvia; Carullo, Gabriele; Ramunno, Anna; Gemma, Sandra; Varani, Katia; Butini, Stefania; Campiani, Giuseppe; Vincenzi, Fabrizio
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition 2022 Papa, A.; Pasquini, S.; Contri, C.; Gemma, S.; Campiani, G.; Butini, S.; Varani, K.; Vincenzi, F.
Synthesis of Unsymmetrical Squaramides as Allosteric GSK-3β Inhibitors Promoting β-Catenin-Mediated Transcription of TCF/LEF in Retinal Pigment Epithelial Cells 2022 Carullo, G.; Bottoni, L.; Pasquini, S.; Papa, A.; Contri, C.; Brogi, S.; Calderone, V.; Orlandini..., M.; Gemma, S.; Varani, K.; Butini, S.; Galvagni, F.; Vincenzi, F.; Campiani, G.
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications 2022 Pasquini, Silvia; Contri, Chiara; Cappello, Martina; Borea, Pier Andrea; Varani, Katia; Vincenzi,... Fabrizio